Arris Pharmaceutical Corp. offers common stock.SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif.--(BUSINESS WIRE)--March 22, 1996-- Arris ar·ris n. pl. arris or ar·ris·es The sharp edge or ridge formed by two surfaces meeting at an angle, as in a molding. [Alteration of Old French areste, fishbone, spine Pharmaceutical Corp. (Nasdaq:ARRS ARRS American Roentgen Ray Society. ) announced today the public offering of 3,000,000 shares of common stock by the company at a price of $13.00 per share. Cowen & Co., Hambrecht & Quist LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control and Robertson Stephens & Co. LLC are co-underwriters of the offering. The company expects to use the net proceeds Net Proceeds The amount received after all costs are deducted from the sale of a piece of property or security. Notes: In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions). from this offering for research and development activities, including preclinical and clinical testing, and for general corporate purposes, including working capital. Arris Pharmaceutical Corp. uses an integrated drug discovery approach combining structure-based drug design, combinatorial chemistry and its proprietary Delta Technology to discover and develop diverse small molecule therapeutics for existing markets where currently available therapies have significant limitations. Arris' product development programs include: (1) protease-based discovery programs targeting the inhibition of enzymes implicated im·pli·cate tr.v. im·pli·cat·ed, im·pli·cat·ing, im·pli·cates 1. To involve or connect intimately or incriminatingly: evidence that implicates others in the plot. 2. in inflammatory and certain other diseases; and (2) receptor-based discovery programs, including those designed to discover small molecule drugs that mimic important therapeutic proteins. A prospectus may be obtained by contacting the Prospectus Department at Cowen & Co., One Financial Square, New York, NY 10005, 212/495-8923; Hambrecht & Quist LLC, One Bush St., San Francisco, CA 94104, 415/576-3300, or 230 Park Ave., New York, NY 10169, 212/207-1400; or Robertson Stephens & Co. LLC, 555 California St., Ste. 2600, San Francisco, CA 94104, 415/781-9700. CONTACT: Arris Pharmaceutical Corp. Daniel H. Petree or Shari Annes, 415/829-1000 http://www.arris.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion